Authors:

Busse quenby S. Farquharson RG.

Institution:

Women's Hospital, Catharine Street,Liverpool L8 7NJ; United Kingdom.

Title:

Human chorionic gonadotropin supplementation in recurring pregnancy loss: A controlled trial (1994-404).

Source:

Fertility and Sterility. Vol 62(4) (pp08-710), 1994.

Abstract:

Objectives:

To investigate the efficacy of hCG in the management of recurrent early pregnancy loss.

Design:

A prospective, randomized, controlled trial.

Setting:

Miscarriage Clinic, Women's Hospital, Liverpool, United Kingdom. Subjects: Eighty-one women attending the miscarriage clinic with idiopathic recurrent pregnancy loss were randomized to receive hCG supplementation or placebo in early pregnancy.

Main Outcome Measure:

The success rate or live birth rate.

Results:

In women with regular menstrual cycles it was found that hCG had no beneficial effect, the pregnancy success rate being 86% in both groups. However, women with oligomenorrhea had a pregnancy success rate of 40% in the placebo group but a statistically significant improvement to 86% if hCG was given.

Conclusions:

Human chorionic gonadotropin can be recommended for idiopathic recurrent pregnancy loss in women with oligomenorrhea.



Women's Health



women's health


Please click on the required question.

Women's Health

Thank you for choosing to visit us.


This is the personal website of David A Viniker MD FRCOG, Consultant Obstetrician and Gynaecologist at Whipps Cross University Hospital, London - Specialist Interests - Reproductive Medicine including Infertility, PCOS, PMS, Menopause and HRT.

I do hope that you find the answers to your women's health questions in the patient information and medical advice provided.





Keyword SEO Pro



Single Page

SEO Videos